What is CRISPR Therapeutics's total assets?

CRISPR Therapeutics (CRSP) reported total assets of $2.73B in Q1 2026.

How has CRISPR Therapeutics's total assets changed year-over-year?

CRISPR Therapeutics's total assets increased by 25.8% year-over-year, from $2.17B to $2.73B.

What is the long-term trend for CRISPR Therapeutics's total assets?

Over 5 years (2020 to 2025), CRISPR Therapeutics's total assets has grown at a 4.4% compound annual growth rate (CAGR), from $1.83B to $2.27B.

What does total assets mean?

The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.

CRISPR Therapeutics CRSP Total Assets

Total Assets at other companies

Beam TherapeuticsBEAM

$1.48B+0.9%

Cogent Biosciences, Inc.COGT

$903.01M+218%

CelcuityCELC

$410.16M+88.0%

Arrowhead ResearchARWR

$2.27B+44.2%

Krystal Biotech, Inc.KRYS

$1.4B+30.0%

Spyre Therapeutics, Inc.SYRE

$763.95M+34.1%

Other financials

Income statement

See full

Revenue$1.5M+68.6%

Operating income-$130.2M+12.2%

Net income-$122.9M+9.6%

EPS (diluted)-$1.28+19.0%

Balance sheet

See full

Cash & equivalents$423.3M+80.0%

Total debt$787.6M+259%

Total equity$1.8B-0.8%

Cash flow

See full

Operating cash flow-$108.9M-102%

CapEx$504.0K+145%

Free cash flow-$109.4M-102%

Valuation

See full

Market cap$5.33B+56.4%

Profitability

See full

Operating margin-15,754.2%-17,253pp

Net margin-13,856.5%-15,058pp

FCF margin-9,777.6%-10,759pp

Returns & leverage

See full

Return on equity-31.2%+43.7pp

Debt / equity0.4×+0.3×

Current ratio18×+2.3×

Where this comes from

Reported directly by CRISPR Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: CRISPR Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about CRISPR Therapeutics's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CRISPR Therapeutics's total assets?: CRISPR Therapeutics (CRSP) reported total assets of $2.73B in Q1 2026.
How has CRISPR Therapeutics's total assets changed year-over-year?: CRISPR Therapeutics's total assets increased by 25.8% year-over-year, from $2.17B to $2.73B.
What is the long-term trend for CRISPR Therapeutics's total assets?: Over 5 years (2020 to 2025), CRISPR Therapeutics's total assets has grown at a 4.4% compound annual growth rate (CAGR), from $1.83B to $2.27B.
What does total assets mean?: The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.